EnClear Therapies’ system designed to treat amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases was one of five first-place winners of the Massachusetts Life Sciences Center (M2D2) $200K Challenge. Cambridge, Mass.-based EnClear Therapies’ device-based system was designed to halt the progression of neurodegenerative diseases by removing toxic proteins that build up in the brain and […]